Analysis on the Hospitalization Expenses for Acute Leukemia in China from 2013 to 2021
Objectives To explore the composition and trend of hospitalization expenses in acute leukemia,and provide a research basis for effectively controlling the unreasonable growth of medical expenses.Methods To collect relevant information on hospitalization expenses for acute leukemia from 2013 to 2021 in the statistical yearbook,use Excel to display the changes in expenses and calculate the annual growth rate.Use grey correlation analysis to analyze the correlation degree of hospitalization expenses for acute leukemia in China from 2013 to 2021.Use structural change analysis to analyze the overall characteristics of expense composition and the dynamic trend of internal structure of expenses,and identify the main factors affecting the changes in medical expenses.Results From 2013 to 2021,the average medical expenses for acute leukemia increased year by year,with an average annual growth rate of 8.45%;Grey correlation analysis showed that the highest correlation among hospitalization expenses was drug expenses(1.00),followed by treatment expenses(0.72),examination expenses(0.72),sanitary material expenses(0.71),and surgical expenses(0.69).The analysis of structural change showed that the summary structural change of hospitalization expenses for acute leukemia patients from 2013 to 2021 was 13.25%,with the largest change from 2016 to 2017.The medical expenses with the largest change in hospitalization expenses were drug expenses,and the contribution rate of structural change in hospitalization expenses was also drug expenses.The high cost of drugs was the main influencing factor for the increase in hospitalization expenses.Conclusions The inpatient expenses of acute leukemia increased year by year,and the drug expense was the main factor,followed by the treatment expense and the examination expense.It was suggested to establish a scientific evaluation index system for expense control,continuously optimize clinical pathways,standardize diagnosis and treatment behaviors,rationally reduce drug expense,and take multiple measures to reduce the economic burden of acute leukemia patients.
NETL
NSTL
万方数据
